Business Context and Reporting Period
Company: Ultralife Batteries, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 26, 2004
Business Overview: The Company develops, manufactures, and markets lithium primary (non-rechargeable) and lithium ion/polymer rechargeable batteries for military, industrial, and consumer applications. Operations are reported in three segments: Primary Batteries, Rechargeable Batteries, and Technology Contracts.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 26, 2004 |
Six Months Ended June 26, 2004 |
Six Months Ended June 28, 2003 |
|---|---|---|---|
| Revenues | $28,439 | $55,427 | $35,538 |
| Gross Margin | $7,048 (25%) | $13,380 (24%) | $7,890 (22%) |
| Operating Income | $3,630 | $6,988 | $2,510 |
| Net (Loss) Income | $(372) | $2,863 | $2,460 |
| Diluted EPS | $(0.03) | $0.19 | $0.19 |
| Cash and Equivalents | $941 | $941 | $1,612 |
| Total Debt (Short & Long Term) | $5,507 | $5,507 | $8,363 |
| Operating Cash Flow (6mo) | N/A | $1,819 | $(243) |
Note: Debt figures include short-term debt and current portion of long-term debt ($5,439) plus long-term debt ($68) as of June 26, 2004.
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 41% ($8.3M) for the quarter and 56% ($19.9M) for the six months compared to the prior year. This was driven primarily by a 34% increase in Primary Battery sales, led by strong shipments of BA-5390 military batteries.
- Margin Expansion: Gross margin improved to 25% for the quarter (from 24% prior year) and 24% for the six months (from 22% prior year), attributed to volume increases and manufacturing efficiencies.
- Significant Non-Operating Charge: The Company recorded a $3.951 million non-cash, non-operating charge in June 2004 related to the write-off of its investment and note receivable in Ultralife Taiwan, Inc. (UTI). This charge caused a net loss for the quarter despite positive operating income.
- Fire Incidents: Two fires occurred in May and June 2004 at U.S. and U.K. facilities. The Company recorded write-downs of $543,000 for inventory and $112,000 for fixed assets. Management expects full insurance reimbursement for approximately $2.0 million in total losses.
- Debt Reduction: Total debt decreased significantly from the prior year due to principal payments and a reduction in revolving credit facility usage.
Guidance, Outlook, and Risks
Guidance and Outlook
- 2004 Revenue: Reaffirmed guidance of $106 million for the full year (approx. 33% increase over 2003).
- 2004 Operating Income: Expected to be approximately $12.5 million for the full year.
- 2005 Outlook: Projected consolidated revenues of $125 million to $135 million, with rechargeable revenues expected to double to approximately $14 million.
- Capital Expenditures: Projected spend of $5 million to $6 million for 2004 to enhance capacity and productivity.
Risks and Contingencies
- Military Procurement Uncertainty: Potential disruption in BA-5390 order flow due to the October 2004 transfer of procurement authority from CECOM to the Defense Logistics Agency (DLA) and the pending Next Gen II Phase IV contract award.
- Environmental Liability: Ongoing remediation of contaminated soil and groundwater at the Newark, NY facility. While a liability has been reserved, final costs could exceed estimates.
- UTI Investment: Continued uncertainty regarding the financial viability of Ultralife Taiwan, Inc., though management believes alternate supply sources mitigate operational risk.
- Net Operating Loss (NOL) Limitation: A change in ownership in late 2003 limits the annual utilization of NOL carryforwards to approximately $14 million to $18 million, potentially resulting in future cash tax outlays.
Subsequent Event
On June 30, 2004, the Company closed a new $25 million credit facility ($10 million term loan, $15 million revolver) with JP Morgan Chase Bank and Manufacturers and Traders Trust Company, replacing the expiring facility.
Investor Verification Checklist
- UTI Write-off Impact: Verify the non-recurring nature of the $3.951 million charge and confirm that UTI remains a viable supplier despite the financial write-off.
- Insurance Recovery: Monitor the status of insurance claims related to the May and June 2004 fires to ensure the expected $2.0 million reimbursement is realized.
- Military Contract Awards: Track the outcome of the Next Gen II Phase IV contract award and the transition of procurement authority to DLA to validate the $106 million revenue guidance.
- Environmental Remediation: Review updates from the New York State Department of Environmental Conservation (NYSDEC) regarding the Newark facility to assess potential cost overruns.
- Debt Covenant Compliance: Confirm continued compliance with the new credit facility covenants, specifically the debt-to-earnings ratio requirements.